PETOGEN 150 mg/mL Injection

Product Overview

Development Status: Limited Market Approval

Target: Female

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Long-acting

Description: Each 1 mL contains 150 mg of medroxyprogesterone acetate.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Post-development

Project Stage: Marketed

Status Details:
  • The prequalification of Petogen by WHO is underway, and this product has recently obtained ERP, level 3, approval by UNFPA. It has been marketed in a limited number of countries for over two countries.

Download Product Report